Continuous Renal Replacement Therapy Market Research and Forecast by 2027

The global Continuous Renal Replacement Therapy Market was worth US$ 1 Billion in the year 2021 and is poised to reach US$ 1.68 Billion by the year 2027 at a CAGR of 7.7% between 2021 and 2027.

Continuous Renal Replacement Treatment includes the removal of solutes from the blood using hemofiltration, hemodialysis, or both. The therapy lasts nearly 24 hours in an Intensive Care Unit (ICU), distinguishing it from other types of standard renal replacement therapies such as IHD (Intermittent Hemodialysis), which lasts 4-6 hours (at times, even less).

The leading players are embracing technological improvements in acute therapy. For example, Baxter International Inc. cleared their integrated TherMax blood warmer and PrisMax system for TPE (therapeutic plasma exchange) and continuous renal replacement therapy in 2019.

Software integration is being considered as a unique technique for executing continuous renal replacement therapy efficiently and safely. Baxter has developed the PRISMAFLEX system to aid with critical care. It is one of the adaptable platforms that provides individualised medicines at the patients' convenience. Diapact Continuous Renal Replacement Therapy (CRRT) from B. Braun also allows for crucial blood filtration.

Competitive Landscape:

Some of the key players featured in the report include Fresenius Medical Care AG & Co. KGaA; Baxter International Inc.; B. Braun Melsungen AG; Medica SpA; Nikkiso Co., Ltd.; Nipro corp.; Toray Medical Co., Ltd.; NxStage Medical, Inc.; Asahi Kasei Corp. and Medtronic plc.

Read More@ https://www.futuremarketinsights.com/reports/continuous-renal-replacement-therapy-market

Segmentation:

The report offers a comprehensive taxonomy of the continuous renal replacement therapy market based on product type, end user and region. Continuous renal replacement therapy is sold in two types: systems and consumables. The consumables segment covers various types of hemofilter sets, solutions and other accessories.

Increasing healthcare spending in emerging nations is predicted to foster the formation of new multi-specialties in dialysis centres and hospitals, hence increasing demand for CRRT. The market for continuous renal replacement treatment has been studied in several regions, including North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan, Japan, and the Middle East and Africa.

Comments

Post a Comment

Popular posts from this blog

Targeted Therapies for Sandhoff Disease | Assessing the Global Market Landscape

Image
The global Sandhoff Disease Therapeutics Market Size is expected to be worth US$ 10 million in 2023 and US$ 17.91 million by 2033, with a CAGR of 6% from 2023 to 2033. From 2018 to 2022, the Sandhoff Disease Treatments market increased at a 4% CAGR. According to the most recent studies, Sandhoff sickness is a rare disorder that affects 1 in 1,000,000 people. The rising demand for these medications is projected to spur the discovery of novel therapies, propelling the market forward in the coming years. Gene therapy is being investigated as a potential treatment for Sandhoff disease. The therapy restores the ability to break down GM2 ganglioside by delivering a functional copy of the missing enzyme into the patient's cells. This has the potential to reduce or stop disease progression while also improving patient quality of life. Key Takeaways from the Market Study   The Sandhoff Disease Therapeutics market increased at a 4% CAGR from 2018 to 2022. From 2023 to 2033, the global Sandh
Read more

A Safer Tomorrow | Emerging Trends in Hospital-Acquired Infection Control Market

Image
According to Future Market Insights' recently released Hospital-acquired Infection Control Market analysis report, global Hospital-acquired Infection Control sales in 2023 are expected to be US$ 6.5 billion. The market is expected to increase at a CAGR of 7% between 2023 and 2033, reaching $12.7 billion by 2033. Hospitals and intensive care units are predicted to create significant income in the market, with a CAGR of 7.6%. The occurrence of hospital-acquired infections, increasing proportion of surgical procedures, growing geriatric population and increasing prevalence of chronic diseases, technological advancements in sterilisation equipment, and growing awareness of environmental and personal hygiene are the key factors driving the Hospital-acquired infection control market. The increased use of e-beam sterilisation, as well as the reintroduction of ethylene oxide sterilisation, is predicted to increase demand for hospital-acquired infection management. The percentage of treatm
Read more

Transforming Trauma | Emerging Therapies and Interventions in Post-Traumatic Stress Disorder Treatment Market

Image
According to Future Market Insights, the Post-Traumatic Stress Disorder (PTSD) Treatment Market Sales would grow at a 5% CAGR between 2023 and 2033. By 2033, the global market for post-traumatic stress disorder (PTSD) therapy is expected to reach US$ 27.37 billion. The market's growth might be attributed to the increased prevalence of PTSD globally. According to the National Centre for PTSD, approximately 7-8% of the US population will develop PTSD at some point in their lives, with greater percentages among military veterans and persons who have experienced sexual assault or other types of trauma. The COVID-19 pandemic has also been highlighted as a possible cause of PTSD, with healthcare workers, first responders, and people immediately impacted by the virus being especially vulnerable. In addition, there is a growing emphasis on using digital therapies and other non-pharmacological techniques to treat PTSD. For example, virtual reality exposure treatment (VRET) has shown potent
Read more